Olmetec and Rituxan drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Olmetec (olmesartan medoxomil) and Rituxan (rituximab). Common drug interactions include febrile neutropenia among females and haemoglobin decreased among males.
The phase IV clinical study analyzes what interactions people have when they take Olmetec and Rituxan. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.
What is Olmetec?
Olmetec has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 7,904 Olmetec users. Check the latest studies of Olmetec.
What is Rituxan?
Rituxan has active ingredients of rituximab. It is often used in rheumatoid arthritis. eHealthMe is studying from 64,791 Rituxan users. Check the latest studies of Rituxan.
38 people who take Olmetec and Rituxan together, and have interactions are studied.

What are the common drug interactions of Olmetec and Rituxan, by gender? *:
female:
- Febrile neutropenia (fever with reduced white blood cells)
- Helicobacter infection (helicobacter pylori (h. pylori) infects stomach)
- Hepatic pain (pain in liver)
- Inflammation
- Pruritus (severe itching of the skin)
- Renal impairment (severely reduced kidney function)
- Septic shock (shock due to blood infection)
- Throat irritation
- Blood immunoglobulin g decreased
- Blood immunoglobulin m decreased
male:
- Haemoglobin decreased
- Blood beta-d-glucan increased
- Oedema peripheral (superficial swelling)
- Oral infection
- Platelet count decreased
- Pneumonia bacterial (pneumonia associated with bacterial infection)
- Pneumonia staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus)
- Post transplant lymphoproliferative disorder
- Pyrexia (fever)
- Renal failure (kidney dysfunction)
What are the common drug interactions of Olmetec and Rituxan, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Perfume sensitivity
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Altered state of consciousness (altered state of mind)
- Collagen disorder (infection and weakness of collagen)
- Nystagmus (a condition of involuntary eye movement)
- Optic nerve infarction (optic nerve fibre damage)
- Pulmonary alveolar haemorrhage (acute bleeding)
- Renal impairment (severely reduced kidney function)
- Nasopharyngitis (inflammation of the nasopharynx)
- Blood beta-d-glucan increased
50-59:
- Anxiety
- Depression
- Gastric disorder (disease of stomach)
- Osteoporosis (bones weak and more likely to break)
- Spinal disorder (disease of spine a back bone)
- Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
60+:
- Arthralgia (joint pain)
- Infusion related reaction
- Cough
- Arrhythmia (irregular heartbeat)
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Blood pressure diastolic decreased
- Blood pressure fluctuation
- Blood pressure systolic increased
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Dizziness
What are the existing conditions these people have? *
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 18.42%
- Arrhythmias (irregular heartbeat): 6 people, 15.79%
- Insomnia (sleeplessness): 4 people, 10.53%
- Hyperuricaemia (level of uric acid in the blood that is abnormally high): 4 people, 10.53%
- Constipation: 4 people, 10.53%
- Idiopathic Thrombocytopenic Purpura (Itp) (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 3 people, 7.89%
- High Blood Cholesterol: 3 people, 7.89%
* Approximation only. Some reports may have incomplete information.
Do you take Olmetec and Rituxan?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Olmetec and Rituxan:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Olmetec:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Rituxan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Olmetec and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rituxan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on olmesartan medoxomil and rituximab (the active ingredients of Olmetec and Rituxan, respectively), and Olmetec and Rituxan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Vitamin B1 and Hydroxocobalamin - a second ago
- Could Mirtazapine cause Low Birth Weight Baby? - 2 seconds ago
- Vitamins and Tubal Pregnancy for Women aged 20-29 - 15 seconds ago
- Vitamins and Cervical Pregnancy for Women aged 20-29 - 15 seconds ago
- Vitamins and Abdominal Pregnancy for Women aged 20-29 - 16 seconds ago
- Swelling and drugs of ingredients of iloprost - 16 seconds ago
- Vitamins and Ectopic Pregnancy for Women aged 20-29 - 16 seconds ago
- Bradypnea and drugs of ingredients of amlodipine besylate; telmisartan - 18 seconds ago
- Motrin vs. Lortab, side effect and effectiveness comparison - 20 seconds ago
- High Blood Pressure and Toxic Anterior Segment Syndrome - 28 seconds ago